vinorelbine agila vinorelbine (as tartrate) 50 mg/5 ml concentrated injection vial
alphapharm pty ltd - vinorelbine tartrate -
vinorelbine agila vinorelbine (as tartrate) 10 mg/1 ml concentrated injection vial
alphapharm pty ltd - vinorelbine tartrate -
hospira vinorelbine 10 mg/1 ml sterile concentrate vial
hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine is indicated in the treatment of: - non-small cell lung cancer (stage 3 or 4) - as a single agent to patients with metastatic breast cancer (stage 4), where treatment with anthracycline- and taxane containing chemotherapy has failed or is not appropriate
vinorelbine pierre fabre
new zealand medical & scientific ltd - vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine - solution for injection - 10 mg/ml - active: vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine excipient: water for injection
vinorelbine
rex medical ltd - vinorelbine tartrate 13.85 mg/ml equivalent to vinorelbine 10 mg/ml - concentrate for injection - 10 mg/ml - active: vinorelbine tartrate 13.85 mg/ml equivalent to vinorelbine 10 mg/ml excipient: nitrogen sodium hydroxide water for injection - second-line treatment of advanced breast cancer, as a single agent or in combination.
vinorelbine pierre fabre
pierre fabre medicament australia pty ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water titanium dioxide
vinorelbine pierre fabre
pierre fabre medicament australia pty ltd - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg - soft gelatin capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide red macrogol 400 medium-chain triglycerides purified water titanium dioxide
vinorelbine pierre fabre
pierre fabre medicament australia pty ltd - vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg - soft gelatin capsule - 40 mg - active: vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide red iron oxide yellow macrogol 400 medium-chain triglycerides purified water titanium dioxide
vinorelbine pierre fabre
pierre fabre medicament australia pty ltd - vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg - soft gelatin capsule - 80 mg - active: vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water titanium dioxide
vinorelbine kabi
fresenius kabi australia pty limited - vinorelbine tartrate -